TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -1 | -1 | 12 | -7 | -20 | -53 | -12 |
| S | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/13 16:09 | 11/6/13 | ACT | Actavis Plc | L2 | Health | Drug | Pharmaceutical Preparations | Howson Tamar D | L2 | D | S | -47 | 157.34 | 0 | 0 | -24 | 1 | D | |||||||||||||||
7/6/10 19:18 | 7/1/10 | OXGN | Oxigene Inc | DE | Health | BioPrd | Biological Products, (No Diag | Howson Tamar D | CA | D | S | -10 | 0.3900 | 0 | -25 | -33 | 50 | D | -74 | -85 | -73 | -74 | -64 | -47 | -31 | -16 | -1 | -1 | 12 | -7 | -20 | -53 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |